381 related articles for article (PubMed ID: 11070168)
1. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell.
Babcock GJ; Hochberg D; Thorley-Lawson AD
Immunity; 2000 Oct; 13(4):497-506. PubMed ID: 11070168
[TBL] [Abstract][Full Text] [Related]
2. EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency.
Kurth J; Spieker T; Wustrow J; Strickler GJ; Hansmann LM; Rajewsky K; Küppers R
Immunity; 2000 Oct; 13(4):485-95. PubMed ID: 11070167
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.
Hochberg D; Middeldorp JM; Catalina M; Sullivan JL; Luzuriaga K; Thorley-Lawson DA
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):239-44. PubMed ID: 14688409
[TBL] [Abstract][Full Text] [Related]
4. Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils.
Joseph AM; Babcock GJ; Thorley-Lawson DA
J Virol; 2000 Nov; 74(21):9964-71. PubMed ID: 11024124
[TBL] [Abstract][Full Text] [Related]
5. Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors.
Babcock GJ; Thorley-Lawson DA
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12250-5. PubMed ID: 11035774
[TBL] [Abstract][Full Text] [Related]
6. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
Kalla M; Hammerschmidt W
Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
[TBL] [Abstract][Full Text] [Related]
7. Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils.
Hudnall SD; Ge Y; Wei L; Yang NP; Wang HQ; Chen T
Mod Pathol; 2005 Apr; 18(4):519-27. PubMed ID: 15696119
[TBL] [Abstract][Full Text] [Related]
8. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus colonization of tonsillar and peripheral blood B-cell subsets in primary infection and persistence.
Chaganti S; Heath EM; Bergler W; Kuo M; Buettner M; Niedobitek G; Rickinson AB; Bell AI
Blood; 2009 Jun; 113(25):6372-81. PubMed ID: 19351961
[TBL] [Abstract][Full Text] [Related]
10. EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.
Li C; Romero-Masters JC; Huebner S; Ohashi M; Hayes M; Bristol JA; Nelson SE; Eichelberg MR; Van Sciver N; Ranheim EA; Scott RS; Johannsen EC; Kenney SC
PLoS Pathog; 2020 Jun; 16(6):e1008590. PubMed ID: 32542010
[TBL] [Abstract][Full Text] [Related]
11. EBV persistence involves strict selection of latently infected B cells.
Joseph AM; Babcock GJ; Thorley-Lawson DA
J Immunol; 2000 Sep; 165(6):2975-81. PubMed ID: 10975805
[TBL] [Abstract][Full Text] [Related]
12. EBV persistence in memory B cells in vivo.
Babcock GJ; Decker LL; Volk M; Thorley-Lawson DA
Immunity; 1998 Sep; 9(3):395-404. PubMed ID: 9768759
[TBL] [Abstract][Full Text] [Related]
13. Germinal center cytokine driven epigenetic control of Epstein-Barr virus latency gene expression.
Liao Y; Yan J; Beri NR; Giulino-Roth L; Cesarman E; Gewurz BE
PLoS Pathog; 2024 Apr; 20(4):e1011939. PubMed ID: 38683861
[TBL] [Abstract][Full Text] [Related]
14. Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection.
Yoshioka M; Kikuta H; Ishiguro N; Ma X; Kobayashi K
J Gen Virol; 2003 May; 84(Pt 5):1133-1140. PubMed ID: 12692278
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Epstein-Barr virus infection models in a series of pediatric carriers from a developing country.
Vistarop AG; Cohen M; De Matteo E; Preciado MV; Chabay PA
Sci Rep; 2016 Mar; 6():23303. PubMed ID: 26988293
[TBL] [Abstract][Full Text] [Related]
16. The Long and Complicated Relationship between Epstein-Barr Virus and Epithelial Cells.
Hutt-Fletcher LM
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795426
[TBL] [Abstract][Full Text] [Related]
17. Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma.
Araujo I; Foss HD; Hummel M; Anagnostopoulos I; Barbosa HS; Bittencourt A; Stein H
J Pathol; 1999 Feb; 187(3):326-30. PubMed ID: 10398087
[TBL] [Abstract][Full Text] [Related]
18. Dual EBNA1 promoter usage by Epstein-Barr virus in human B-cell lines expressing unique intermediate cellular phenotypes.
Taylor KA; Wetzel S; Lyles DS; Pollok BA
J Virol; 1994 Oct; 68(10):6421-31. PubMed ID: 8083980
[TBL] [Abstract][Full Text] [Related]
19. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
Cordier M; Calender A; Billaud M; Zimber U; Rousselet G; Pavlish O; Banchereau J; Tursz T; Bornkamm G; Lenoir GM
J Virol; 1990 Mar; 64(3):1002-13. PubMed ID: 2154588
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells.
Ehlin-Henriksson B; Mowafi F; Klein G; Nilsson A
Immunology; 2006 Mar; 117(3):379-85. PubMed ID: 16476057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]